Mark S. Levine is CLO at Immunovant, Inc. (IMVT). They have made 21 open-market trades across 3 companies since 2017, most recently 2024-11-20.
CIK 0001617236
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2024-11-20 | 2024-11-22 | $25.45 | $186K | +4.4% | -5.3% | -24.8% |
| IMVT | SELL | 2024-10-23 | 2024-10-25 | $29.53 | $258K | +3.3% | -11.6% | -23.1% |
| IMVT | SELL | 2024-10-16 | 2024-10-18 | $28.79 | $165K | +2.3% | -13.6% | -19.3% |
| IMVT | SELL | 2024-08-21 | 2024-08-23 | $31.85 | $206K | +3.8% | -12.5% | -18.1% |
| IMVT | SELL | 2024-07-24 | 2024-07-26 | $27.76 | $223K | -7.0% | +10.3% | +5.1% |
| IMVT | SELL | 2024-07-17 | 2024-07-19 | $29.67 | $144K | +3.1% | +10.6% | +3.8% |
| IMVT | SELL | 2024-05-22 | 2024-05-24 | $29.65 | $192K | -12.7% | -6.1% | +7.8% |
| IMVT | SELL | 2024-04-24 | 2024-04-26 | $28.90 | $229K | +8.9% | +4.0% | +1.8% |
| IMVT | SELL | 2024-04-17 | 2024-04-19 | $29.06 | $571K | -0.2% | +8.0% | -0.6% |
| IMVT | SELL | 2024-02-22 | 2024-02-23 | $36.15 | $154K | -9.8% | -14.8% | -22.5% |
| IMVT | SELL | 2024-01-26 | 2024-01-29 | $37.91 | $228K | -8.9% | -2.8% | -29.0% |
| IMVT | SELL | 2023-11-22 | 2023-11-24 | $32.78 | $107K | +16.8% | +32.2% | +7.7% |
| IMVT | SELL | 2023-10-25 | 2023-10-27 | $34.66 | $285K | -0.6% | -0.1% | +13.8% |
| IMVT | SELL | 2023-08-24 | 2023-08-25 | $20.30 | $499K | +14.7% | +1.1% | +66.6% |
| IMVT | SELL | 2023-07-26 | 2023-07-27 | $21.63 | $169K | -0.0% | -3.4% | +55.9% |
| IMVT | SELL | 2023-04-25 | 2023-04-26 | $16.29 | $43K | +20.4% | +31.2% | +35.5% |
| IMVT | SELL | 2023-01-26 | 2023-01-27 | $18.51 | $376K | +6.0% | -2.0% | -8.7% |
| FLXN | SELL | 2021-07-19 | 2021-07-20 | $6.45 | $25K | -13.2% | -35.6% | +36.3% |
| FLXN | SELL | 2021-01-05 | 2021-01-07 | $11.13 | $152K | -5.0% | +4.7% | -33.1% |
| FLXN | SELL · 10b5-1 | 2019-01-03 | 2019-01-04 | $12.36 | $9K | +1.4% | +6.5% | -5.4% |
| NERV | SELL | 2017-06-01 | 2017-06-05 | $11.00 | $193K | +3.2% | +3.2% | -30.5% |
| NERV | SELL | 2017-01-04 | 2017-01-06 | $12.00 | $210K | -15.7% | -12.0% | -40.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.